Market Overview:
The global neuropathic pain management market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of neuropathic pain, rising geriatric population, and technological advancements in the field of neuropathic pain management. Based on type, the global neuropathic pain management market is segmented into tricyclic antidepressant, anticonvulsant, opioid, steroid drug, local anesthesia and other segments. Tricyclic antidepressants are expected to dominate the market during the forecast period owing to their high efficacy and safety profile. Anticonvulsants are also expected to witness significant growth during the forecast period due to their ability to control seizures and reduce nerve inflammation. Based on application, retail pharmacy accounted for majority share of the global Neuropathic Pain Management Market in 2017 followed by hospital pharmacy segment. However; hospital pharmacy segment is projected grow at a higher CAGR as compared with retail pharmacy during 2018-2030 owing growing number of hospitals across globe coupled with increasing demand for better treatment options for chronic diseases such as cancer & diabetes mellitus which leads patients towards seeking specialized treatments such as those offered by hospitals pharmacies rather than general pharmacies .
Product Definition:
Neuropathic pain management is the medical specialty that deals with the diagnosis and treatment of neuropathic pain. This type of pain can be caused by damage to or dysfunction of the nervous system and can occur in any part of the body. Neuropathic pain may be chronic or acute, and can range from mild to severe. It is often difficult to treat, and can significantly impair quality of life. Treatment options include medications, surgery, physical therapy, and other interventions.
Tricyclic Antidepressant:
Tricyclic antidepressants are a class of drug used for the treatment of depression. They are also used in neuropathic pain management, but with less success as compared to non-neuropathic pain treatments.
Anticonvulsant:
Anticonvulsants are a class of drug used to prevent or reduce seizures. They can be used in the treatment of generalised or partial seizures, as well as in some cases where nocturnal epilepsy is observed. Anticonvulsants are also sometimes used for other conditions such as neuropathic pain and bipolar disorder.
Application Insights:
Based on application, the market is segmented into retail pharmacy, hospital pharmacy and others. The other applications include dental neuropathy and pain management clinics. In 2017, the hospital pharmacies dominated with a share of over 80% in terms of revenue. This may be attributed to factors such as presence of dedicated hospitals for pharmacists and availability of advanced medicines that are used for pain management in case of emergencies at low cost.
The retail pharmacies also accounted for a significant share owing to presence of well-established healthcare facilities at primary level where people go with acute pains or conditions requiring immediate medical attention.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of key players, availability of advanced technologies and high prevalence of neuropathic pain are some factors attributing to its dominance. In addition, increasing government initiatives for the development and approval of novel therapeutics is also expected to drive growth during the forecast period. For instance, in May 2018, Sun Pharma launched Ucbilistic 25 mg film-coated tablets for treating diabetic peripheral neuropathy (DPN) under brand name Tricyclic antidepressant (TCA) class drug Aloxi in India.
Asia Pacific is anticipated to be one of the fastest growing regions over the forecast period owing to rising disposable income leading towards better healthcare facilities along with improving access & penetration rates for antineuropathic pain therapeutics especially TCA class drugs such as amitriptyline hydrochloride.
Growth Factors:
- Increasing incidence of neuropathic pain
- Growing demand for better and more effective treatment options for neuropathic pain
- Rising awareness about the availability and benefits of neuropathic pain treatments
- Growing number of research studies focused on understanding and treating neuropathic pain
- Technological advances that lead to the development of new and more effective treatments for neuropathic pain
Scope Of The Report
Report Attributes
Report Details
Report Title
Neuropathic Pain Management Market Research Report
By Type
Tricyclic Antidepressant, Anticonvulsant, Opioid, Steroid Drug, Local Anesthesia, Other
By Application
Retail Pharmacy, Hospital Pharmacy, Other
By Companies
Pfizer, Johnson & Johnson Services, Sanofi, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, Biogen Idec, Baxter Healthcare Corporation, Depomed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
133
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Neuropathic Pain Management Market Report Segments:
The global Neuropathic Pain Management market is segmented on the basis of:
Types
Tricyclic Antidepressant, Anticonvulsant, Opioid, Steroid Drug, Local Anesthesia, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail Pharmacy, Hospital Pharmacy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Johnson & Johnson Services
- Sanofi
- GlaxoSmithKline
- Eli Lilly and Company
- Bristol-Myers Squibb
- Biogen Idec
- Baxter Healthcare Corporation
- Depomed
Highlights of The Neuropathic Pain Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tricyclic Antidepressant
- Anticonvulsant
- Opioid
- Steroid Drug
- Local Anesthesia
- Other
- By Application:
- Retail Pharmacy
- Hospital Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neuropathic Pain Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neuropathic pain is a type of chronic pain that is caused by damage to the nervous system. This can happen as a result of an injury, disease, or other condition. Neuropathic pain can be very difficult to treat and can often be debilitating.nnThere are many different types of neuropathic pain, but some common examples include:nnChronic nerve compression syndrome (CNS) u2013 This is a condition in which pressure on the nerves causes intense and long-term nerve pain. It most commonly affects people who have diabetes or multiple sclerosis (MS). CNS may also occur after surgery or trauma to the head and neck area.nn diabetic neuropathy u2013 This type of neuropathy occurs when blood sugar levels become too high and damage occurs to the nerves due to lack of oxygenation. Symptoms may include tingling, numbness, weakness, difficulty walking, bladder problems, sexual dysfunction ,and more . Diabetic neuropathy usually develops over time as diabetes worsens . Treatment options vary depending on how severe the symptoms are .
Some of the major players in the neuropathic pain management market are Pfizer, Johnson & Johnson Services, Sanofi, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, Biogen Idec, Baxter Healthcare Corporation, Depomed.
The neuropathic pain management market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neuropathic Pain Management Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neuropathic Pain Management Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neuropathic Pain Management Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neuropathic Pain Management Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neuropathic Pain Management Market Size & Forecast, 2018-2028
4.5.1 Neuropathic Pain Management Market Size and Y-o-Y Growth
4.5.2 Neuropathic Pain Management Market Absolute $ Opportunity
Chapter 5 Global Neuropathic Pain Management Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Neuropathic Pain Management Market Size Forecast by Type
5.2.1 Tricyclic Antidepressant
5.2.2 Anticonvulsant
5.2.3 Opioid
5.2.4 Steroid Drug
5.2.5 Local Anesthesia
5.2.6 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Neuropathic Pain Management Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Neuropathic Pain Management Market Size Forecast by Applications
6.2.1 Retail Pharmacy
6.2.2 Hospital Pharmacy
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neuropathic Pain Management Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neuropathic Pain Management Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Neuropathic Pain Management Analysis and Forecast
9.1 Introduction
9.2 North America Neuropathic Pain Management Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Neuropathic Pain Management Market Size Forecast by Type
9.6.1 Tricyclic Antidepressant
9.6.2 Anticonvulsant
9.6.3 Opioid
9.6.4 Steroid Drug
9.6.5 Local Anesthesia
9.6.6 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Neuropathic Pain Management Market Size Forecast by Applications
9.10.1 Retail Pharmacy
9.10.2 Hospital Pharmacy
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Neuropathic Pain Management Analysis and Forecast
10.1 Introduction
10.2 Europe Neuropathic Pain Management Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Neuropathic Pain Management Market Size Forecast by Type
10.6.1 Tricyclic Antidepressant
10.6.2 Anticonvulsant
10.6.3 Opioid
10.6.4 Steroid Drug
10.6.5 Local Anesthesia
10.6.6 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Neuropathic Pain Management Market Size Forecast by Applications
10.10.1 Retail Pharmacy
10.10.2 Hospital Pharmacy
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Neuropathic Pain Management Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Neuropathic Pain Management Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Neuropathic Pain Management Market Size Forecast by Type
11.6.1 Tricyclic Antidepressant
11.6.2 Anticonvulsant
11.6.3 Opioid
11.6.4 Steroid Drug
11.6.5 Local Anesthesia
11.6.6 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Neuropathic Pain Management Market Size Forecast by Applications
11.10.1 Retail Pharmacy
11.10.2 Hospital Pharmacy
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Neuropathic Pain Management Analysis and Forecast
12.1 Introduction
12.2 Latin America Neuropathic Pain Management Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Neuropathic Pain Management Market Size Forecast by Type
12.6.1 Tricyclic Antidepressant
12.6.2 Anticonvulsant
12.6.3 Opioid
12.6.4 Steroid Drug
12.6.5 Local Anesthesia
12.6.6 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Neuropathic Pain Management Market Size Forecast by Applications
12.10.1 Retail Pharmacy
12.10.2 Hospital Pharmacy
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Neuropathic Pain Management Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Neuropathic Pain Management Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Neuropathic Pain Management Market Size Forecast by Type
13.6.1 Tricyclic Antidepressant
13.6.2 Anticonvulsant
13.6.3 Opioid
13.6.4 Steroid Drug
13.6.5 Local Anesthesia
13.6.6 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Neuropathic Pain Management Market Size Forecast by Applications
13.10.1 Retail Pharmacy
13.10.2 Hospital Pharmacy
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neuropathic Pain Management Market: Competitive Dashboard
14.2 Global Neuropathic Pain Management Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Johnson & Johnson Services
14.3.3 Sanofi
14.3.4 GlaxoSmithKline
14.3.5 Eli Lilly and Company
14.3.6 Bristol-Myers Squibb
14.3.7 Biogen Idec
14.3.8 Baxter Healthcare Corporation
14.3.9 Depomed
